| Authors: |
Matschiner G; Pieris Pharmaceuticals, Hallbergmoos, Germany. Electronic address: matschiner@pieris.com., Fitzgerald MF; Pieris Pharmaceuticals, Hallbergmoos, Germany., Moebius U; Pieris Pharmaceuticals, Hallbergmoos, Germany., Hohlbaum AM; Pieris Pharmaceuticals, Hallbergmoos, Germany., Gille H; Pieris Pharmaceuticals, Hallbergmoos, Germany., Jensen K; Pieris Pharmaceuticals, Hallbergmoos, Germany., Kirchfeld K; Pieris Pharmaceuticals, Hallbergmoos, Germany., Rattenstetter B; Pieris Pharmaceuticals, Hallbergmoos, Germany., Laforge A; Pieris Pharmaceuticals, Hallbergmoos, Germany., Bel Aiba RS; Pieris Pharmaceuticals, Hallbergmoos, Germany., Ciccotosto J; Lung Health Research Centre, Department of Biochemistry and Pharmacology, University of Melbourne, Parkville, Australia., Nyugen H; Lung Health Research Centre, Department of Biochemistry and Pharmacology, University of Melbourne, Parkville, Australia., Foster ML; Experimental Pathology Consultancy, Benfleet, United Kingdom., Snouwaert JN; University of North Carolina, Chapel Hill, NC., Nguyen M; University of North Carolina, Chapel Hill, NC., Koller BH; University of North Carolina, Chapel Hill, NC., Matis L; Pieris Pharmaceuticals, Boston, Mass., Anderson GP; Lung Health Research Centre, Department of Biochemistry and Pharmacology, University of Melbourne, Parkville, Australia. Electronic address: gpa@unimelb.edu.au., Olwill SA; Pieris Pharmaceuticals, Hallbergmoos, Germany. |
